Neurology Disease Education

Neurology Disease Education

Neurology Disease Education

Migraine in America Symptoms
and Treatment (MAST) Study

The MAST Study is currently the largest longitudinal epidemiologic survey of episodic and chronic migraine in the United States. In this study, 15,313 respondents completed the baseline survey and were followed up again at 6 and 12 months to understand their migraine symptoms, treatment patterns, and progression of disease. The 77,453 survey respondents who did not meet the migraine criteria at baseline were followed up at 12 months to understand the 12-month incidence of migraine.

Authors: Aftab Alam, Ryan Bostic, Dawn Buse, David Dodick, Kristina Fanning, Richard Lipton, Sagar Munjal, Jelena Pavlovic, Michael Reed, and Todd Schwedt

June 2018

Scaling of Unmet Treatment Needs and Associated Disability Among Persons with Migraine: Results from Migraine in America Symptoms and Treatment (MAST) Study

Platform presentation at the American Headache Society 60th Annual Meeting

View the presentation

June 2018

Triptan Use and Discontinuation Among a Population Sample of Persons with Migraine: Results from Migraine in America Symptoms and Treatment (MAST) Study

Platform presentation at the American Headache Society 60th Annual Meeting

View the presentation

June 2018

Most Bothersome Migraine Symptom and Associated Burden: Results from 2017 Migraine in America Symptoms and Treatment (MAST) Study

Poster presentation at the American Headache Society 60th Annual Meeting

View the poster

June 2018

Menstrual Migraine and Associated Pain Onset, Intensity and Interference: Results from the 2017 Migraine in America Symptoms and Treatment (MAST) Study

E-Poster presentation at the American Headache Society 60th Annual Meeting

View the poster

April 2018

Factors Associated with Medication Overuse in Persons with Migraine: Results from the 2017 Migraine in America Symptoms and Treatment (MAST) Study

Platform presentation at the American Academy of Neurology Annual Meeting

View the presentation

April 2018

Predictors of Allodynia in Persons with Migraine: Results from the 2017 Migraine in America Symptoms and Treatment (MAST) Study

Poster presentation at the American Academy of Neurology Annual Meeting

View the presentation

April 2018

2017 Migraine in America Symptoms and Treatment (MAST) Study: Gender Differences in Treatment Patterns and Unmet Treatment Needs

Poster presentation at the American Academy of Neurology Annual Meeting

View the posters

June 2017

Allodynia Is Associated with Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention (AMPP) Study

Harold G. Wolff Lecture Award presentation at the American Headache Society Annual Meeting

View the presentation